Industrial Mixing Tank: Design, Function, and Applications
The design of a mixing tank is determined by the specific requirements of the process it serves. The key design elements include:
Tanks are commonly made from stainless steel, carbon steel, plastic (such as polyethylene or polypropylene), or lined materials for corrosion resistance. Stainless steel is preferred for food-grade and pharmaceutical applications due to its hygienic properties.
Cylindrical tanks with conical or dished bottoms are widely used to enhance mixing efficiency and ease of drainage. Horizontal tanks are used in space-constrained facilities, though vertical tanks offer better mixing performance.
The agitator or mixer is the heart of the mixing tank. Common types include: Propeller Agitators – High-speed mixers for low-viscosity liquids.
– High-speed mixers for low-viscosity liquids. Turbine Agitators – Suitable for mixing medium to high-viscosity fluids.
– Suitable for mixing medium to high-viscosity fluids. Anchor and Paddle Mixers – Ideal for viscous or shear-sensitive products.
Baffles are vertical strips inside the tank that prevent vortex formation and improve mixing. Other features might include heating/cooling jackets, sensors, and CIP (Clean-In-Place) systems.
The primary function of a mixing tank is to create a uniform blend of ingredients. Depending on the process, this could involve: Homogenization: Creating a consistent mixture from multiple components.
Creating a consistent mixture from multiple components. Suspension: Keeping solid particles evenly distributed in a liquid.
Keeping solid particles evenly distributed in a liquid. Emulsification: Blending immiscible liquids like oil and water.
Blending immiscible liquids like oil and water. Heat Transfer: Heating or cooling contents during mixing.
Heating or cooling contents during mixing. Chemical Reactions: Acting as a reactor vessel for mixing reactants.
Control systems allow operators to adjust mixing speed, temperature, and duration, ensuring precise processing tailored to each batch or product type.
Industrial mixing tanks are used in a broad range of applications:
Used for mixing sauces, dairy products, beverages, and flavorings while maintaining hygiene and consistency. Tanks often include temperature control for pasteurization.
Essential for blending chemicals, solvents, or resins. Some tanks are built to withstand high pressures and corrosive substances.
Used for producing liquid medications, vaccines, and personal care products. Precision and cleanliness are critical, often requiring GMP-compliant tanks with sterile mixing environments.
Used for coagulation, flocculation, and chemical dosing processes to treat water or wastewater efficiently.
Tanks mix creams, lotions, shampoos, and gels, often with integrated heating and vacuum systems to achieve the desired texture and stability.
Industrial mixing tanks are indispensable tools for modern production, enabling efficient and reliable processing across industries. Their design is tailored to meet specific processing requirements, and advancements in materials and automation continue to improve their performance and sustainability. Choosing the right tank design and configuration is critical for product quality, process efficiency, and compliance with industry standards.
TIME BUSINESS NEWS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
6 days ago
- The Sun
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR - Media OutReach Newswire - 1 August 2025 - Cushman & Wakefield, a leading global real estate services firm, today released its Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland report. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. Recent national policy initiatives on the Chinese mainland Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The 'R&D + Manufacturing + Service' ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.' Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'. Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'. Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'. Please click here to download the full report.
Arabian Post
6 days ago
- Arabian Post
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR – Media OutReach Newswire – 1 August 2025 –Cushman & Wakefield, a leading global real estate services firm, today released itsreport. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. ADVERTISEMENT Recent national policy initiatives on the Chinese mainland Types of policies Detail information Opening to Foreign Investment In 2024, China eased restrictions on foreign investments in stem cell research, gene therapy, and genetic diagnostics within Free Trade Zones (FTZs) like Beijing, Shanghai, Guangdong, and Hainan. Regulatory Incentives The State Council's Circular No. 53 introduced measures such as regulatory data protection and marketing exclusivity for select pharmaceutical products, including orphan and paediatric drugs. Wholly Foreign-Owned Hospitals China now permits the establishment of wholly foreign-owned hospitals in cities like Beijing, Shanghai, and Shenzhen, enhancing healthcare services and encouraging foreign investment. Source: Cushman & Wakefield Research Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs ADVERTISEMENT Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The 'R&D + Manufacturing + Service' ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.' Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'. Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'. Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'. Please click here to download the full report. Hashtag: #Cushman&Wakefield The issuer is solely responsible for the content of this announcement. About Cushman & Wakefield Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In Greater China, a network of 23 offices serves local markets across the region. In 2024, the firm reported revenue of $9.4 billion across its core services of Valuation, Consulting, Project & Development Services, Capital Markets, Project & Occupier Services, Industrial & Logistics, Retail, and others. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit or follow us on LinkedIn (
Time Business News
30-07-2025
- Time Business News
Industrial Mixing Tank: Design, Function, and Applications
Industrial mixing tanks are a cornerstone of modern manufacturing processes across various sectors, including pharmaceuticals, food and beverage, chemicals, cosmetics, and water treatment. These tanks are engineered to mix, blend, combine, or emulsify substances—typically liquids, powders, and semi-solids—into a homogeneous product. Their design and functionality play a crucial role in ensuring process efficiency, product consistency, and safety. The design of a mixing tank is determined by the specific requirements of the process it serves. The key design elements include: Tanks are commonly made from stainless steel, carbon steel, plastic (such as polyethylene or polypropylene), or lined materials for corrosion resistance. Stainless steel is preferred for food-grade and pharmaceutical applications due to its hygienic properties. Cylindrical tanks with conical or dished bottoms are widely used to enhance mixing efficiency and ease of drainage. Horizontal tanks are used in space-constrained facilities, though vertical tanks offer better mixing performance. The agitator or mixer is the heart of the mixing tank. Common types include: Propeller Agitators – High-speed mixers for low-viscosity liquids. – High-speed mixers for low-viscosity liquids. Turbine Agitators – Suitable for mixing medium to high-viscosity fluids. – Suitable for mixing medium to high-viscosity fluids. Anchor and Paddle Mixers – Ideal for viscous or shear-sensitive products. Baffles are vertical strips inside the tank that prevent vortex formation and improve mixing. Other features might include heating/cooling jackets, sensors, and CIP (Clean-In-Place) systems. The primary function of a mixing tank is to create a uniform blend of ingredients. Depending on the process, this could involve: Homogenization: Creating a consistent mixture from multiple components. Creating a consistent mixture from multiple components. Suspension: Keeping solid particles evenly distributed in a liquid. Keeping solid particles evenly distributed in a liquid. Emulsification: Blending immiscible liquids like oil and water. Blending immiscible liquids like oil and water. Heat Transfer: Heating or cooling contents during mixing. Heating or cooling contents during mixing. Chemical Reactions: Acting as a reactor vessel for mixing reactants. Control systems allow operators to adjust mixing speed, temperature, and duration, ensuring precise processing tailored to each batch or product type. Industrial mixing tanks are used in a broad range of applications: Used for mixing sauces, dairy products, beverages, and flavorings while maintaining hygiene and consistency. Tanks often include temperature control for pasteurization. Essential for blending chemicals, solvents, or resins. Some tanks are built to withstand high pressures and corrosive substances. Used for producing liquid medications, vaccines, and personal care products. Precision and cleanliness are critical, often requiring GMP-compliant tanks with sterile mixing environments. Used for coagulation, flocculation, and chemical dosing processes to treat water or wastewater efficiently. Tanks mix creams, lotions, shampoos, and gels, often with integrated heating and vacuum systems to achieve the desired texture and stability. Industrial mixing tanks are indispensable tools for modern production, enabling efficient and reliable processing across industries. Their design is tailored to meet specific processing requirements, and advancements in materials and automation continue to improve their performance and sustainability. Choosing the right tank design and configuration is critical for product quality, process efficiency, and compliance with industry standards. TIME BUSINESS NEWS
